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Abstract--Selecting medical hardware can be a difficult and 
permanent decision for patients that they are often unprepared 
for. The authors explore the use of pairwise comparison 
techniques to better inform medical decision making in an 
application of choosing between three major cochlear implant 
manufacturers.  This paper appears to be the first study to 
apply a pairwise comparison decision making approach for 
cochlear implant device selection.  Also, unlike many medical 
decision making studies that are developed by the healthcare 
professional, this model and analysis was conducted entirely by 
the patient for the purpose of making the real-world decision of 
a device.  It therefore demonstrates the use of sophisticated 
decision analysis tools to inform complex patient-based medical 
decision making. The hierarchical model was built and used for 
the patient to make a device selection with low values of 
inconsistency.  
 
I. INTRODUCTION 
 
Informed decision making is becoming ever more 
important given the increasing expense of healthcare. Over 
the last decade, this has resulted in a growth of research in a 
wide range of domains of medical decision making. A 
comprehensive survey of decision support systems in patient 
decision making for treatment and screening [1] found that 
across a range of studies, “Decision aids do no better than 
alternative interventions on people’s satisfaction with 
decision making, anxiety, or health outcomes such as quality 
of life or condition specific quality of life.”  Having said that, 
they found that the decision support tools generally helped 
the patient in several other important ways such as 
developing realistic expectations for procedure outcomes.  
A joint report by the National Academies of  Science, 
Engineering, and Medicine focused on hearing treatment for 
adults [2].  They state that “In the United States, an estimated 
30 million individuals (12.7 percent of Americans ages 12 
years or older) have hearing loss in both ears.”  People with 
hearing loss in one ear expands this population still further.  
While their report was focused on hearing aids, many of their 
comments about the decision making challenges faced by 
patients apply to other forms of hearing loss treatment.   
This research study was motivated by the diagnosis of 
profound, single-sided deafness for one of the authors.  For a 
variety of reasons, three separate specialists recommended a 
cochlear implant which then entails selecting a particular 
product.  It quickly became apparent that while there was a 
lot of information, selecting a product was a hard decision-an 
issue for which our field of engineering and technology 
management is well-suited to provide insight.   
 
II. PRELIMINARIES 
 
Making decision can become a very challenging task 
especially when there are multiple criteria to consider that are 
difficult to measure and prioritize. Pairwise comparison is a 
method that breaks down the decision making process into 
simple judgment between two alternatives and also provides a 
way for the decision maker to measure preferences and come 
to a conclusion among alternatives [3]. Buying a car is a very 
common example where there are more than one criterion to 
consider and each one of them can be as important. Sales 
price of the car as well as its maintenance costs, gas millage, 
its engine capacity, its cargo and interior space and durability 
are common criteria to consider. There is not an easy way to 
measure the importance of these criteria and prioritize them. 
Pairwise comparison provides the tools to make the decision 
making process much simpler and enable the decision maker 
to make trade-offs. Analytical Hierarchy Process (AHP) 
developed by Saaty, is a multi-attribute decision making 
methodology that prioritizes alternatives through pairwise 
comparison. It allows incorporating tangible and intangible 
criteria towards making a decision and provides a way to 
measure their priority.  Using AHP, the decision maker 
breaks down the decision into a hierarchy with the lowest 
level being the alternatives and the highest level being the 
goal with criteria and sub-criteria in the levels between the 
two. The decision maker uses pairwise comparisons to set his 
or her relative preference between two alternatives or sub-
criteria with respect to the criterion on the higher level and 
eventually a final priority for the alternatives are obtained [3]. 
This paper uses Hierarchical Decision Model (HDM) which 
is similar to AHP except that HDM uses Constant-Sum 
calculations instead of Eigenvectors in AHP [4]. 
AHP has been widely used in different application areas 
as a decision making methodology. Examples include 
selection of a multi-media authorizing system, equipment 
selection for manufacturing system and selection of best 
management style for improving human performance [5]–[7]. 
Examples of using HDM as decision modeling tool can be 
found in [7-9]. 
In 2008, Liberatore and Nydick [11] did a literature 
review on the application of AHP in medical and health care 
decision making. There are few articles on the subject prior to 
1988, however, the number of articles increased to 3 per year 
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since 1997. The authors reviewed 50 articles and in 
conclusion found AHP as a promising decision making 
support tool in decision making between patient and doctor, 
evaluation and selection of therapists and treatments, and the 
evaluation of health care technologies and policies. Richman, 
et al. [12] applied AHP to develop a physician-patient joint 
decision model for selection of prostate cancer treatment. 
Liberatore, et al. [13] applied AHP as a decision support tool 
for African-American men to decide whether they are willing 
to go under a prostate cancer examination. 
Pecchia, et al. [14] used AHP to synthesize the diverse 
needs for a computed tomography scanner by using medical 
professionals to compare twelve criteria in four categories 
listed in Table 1. While the twelve characteristics are quite 
different for a large CT scanner than for a cochlear implant, 
the four higher level categories are useful. Pecchia, et al., 
used five medical professionals, each with over two decades 
of medical experience. These experts came from five 
different specialties: radiology, ear surgery, neurology, 
emergency neurology, and emergency.  Coincidentally, one 
of these experts (representing ear surgery) specialized in 
pediatric cochlear implants but the context is quite different 
from that of this study. 
 
TABLE 1: AHP CRITERIA USED BY PECCHIA, ET AL. [14] FOR 
EVALUATING CT SCANNERS 
High level Categories Criteria 
Performance  Spatial resolution 
 Speed run 
 Processing software 
Patient Safety  Patient radiation dose 
 Patient monitoring 
 Contrast medium control 
Usability  Application support 
 User-friendly GUI 
 Interoperability 
Technical Issues  On call services 
 Maintenance 
 Data storing 
 
A. Pair wise comparison method in HDM 
HDM uses the Constant-Sum method to calculate the 
priorities of elements on each level in the hierarchical 
decision model with respect to the criteria or goal node in the 
higher level. Consider four criteria cost, gas mileage, cargo 
space and engine capacity for purchasing a car. Let’s call the 
criteria a, b, c and d respectively. The first step is to create 
 possible pairs for the pairwise comparison and in this 
case will be 6 pairs , , , , 	 		 .	The decision 
maker will distribute 100 points between each pair with 
respect to the goal which is purchasing a car. For example, if 
cost is twice as important as gas mileage, in comparing a with 
b, a will be 66 points and b will be 33. If cost and cargo space 
are as important, a and c each will get 50 points. 
The detailed procedures of hierarchical decision modeling 
can be found in a variety of sources  [8]–[10] but 
conceptually, it can be thought of as using the decision maker 
or expert’s elicited relative weights obtained through pairwise 
comparisons to calculate specific weights for each criteria in 
multiple ways.  If the different ways of calculating specific 
weights give different values of specific weights for a single 
decision maker, this difference is ascribed to inconsistency. If 
multiple decision makers are involved and arrive at different 
specific weights, this is termed disagreement.   
 
III. COCHLEAR IMPLANT TECHNOLOGY 
 
Cochlear implants are a sophisticated technology for 
getting audio signals transmitted directly to auditory nerve 
cells, bypassing many of the possible causes of hearing loss. 
Arungiri and Mathew previously studied the development of 
cochlear implant technology in PICMET [15]. 
Fundamentally, a cochlear implant consists of five key 
functional pieces described in Figure 1.   
The external processor is the part that is most visible.  It 
usually has two major external pieces.  The first, labeled A, is 
a device that sits behind the ear (BTE) and includes 
microphone(s), battery(ies), and digital signal processing 
functions in a form that looks similar to many hearing aids.  
A short cord connects the external processor to a magnetic 
disc, B, which transmits both power and the “instructions” for 
the firing of the electrode.  The external magnet, B, is then 
magnetically coupled to an internal magnet, C.  It has a 
similar magnetic disc, some processing electronics, D, and an 
electrode, E, that is then threaded through the skull and/or ear 
structures into the cochlea.  The cochlea is an organ about the 
size of a green pea and this is where the electrode’s firing is 
received by the auditory nerve which is perceived as “sound” 
by the patient.  The external component(s) can be upgraded 
over time but the internal components are intended to last a 
lifetime.  
 
 
 
 
Figure 1.  Functional description of the core components of a modern cochlear implant. 
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The history of cochlear implant technology has roots that 
go back to the early days of electrical exploration in the mid 
eighteenth century when it was discovered that electrical 
stimulation to the ear could potentially allow some form of 
hearing [16].   There were some periodic efforts over the 
years to advance these early results but it took two centuries 
of progress in both the medical and electronics fields before 
work could advance to direct electrical stimulation of the 
auditory nerve in a significant manner.  Modern research 
resulted in significant achievements in the mid 20th century.  
The 1950s saw stimulation near the auditory nerve and the 
1960s had the first implant in the human cochlea and direct 
stimulation of the auditory nerve [17].   Mudry and Mills [16] 
provide a rich and accessible history of the development of 
cochlear implant technology over time.  
Currently there are three companies providing cochlear 
implants in the US:  Advanced Bionics, Cochlear 
Technologies, and Med-El.  There are also at least two other 
manufacturers that are not FDA-approved and therefore 
unavailable in the US including Zheijiang Nurotron 
Biotechnology Co. Ltd. in China which began offering 
cochlear implants in China in 2011.  The French company, 
Neurelec, merged with Oticon Medical and sells the Neuro 
Cochlear Implant System.  For the sake of this paper, we will 
limit our attention to just the products available in the US.   
While the core concept of the product is similar for each 
of the three manufacturers, there are important differences.  
The Australia-based company, Cochlear was started in 1981 
and is estimated to have a 50% market share which can be 
reassuring to some patients when the implanted device will 
be expected to last a lifetime.  Advanced Bionics is the only 
manufacture to use digital encoding of the signal from the 
external unit to the internal unit and generally is recognized 
as having greater future bandwidth potential.  Med-El is 
based in Austria and was founded in 1977.  It is the only 
manufacturer to offer an option to integrate the two external 
devices (labeled A and B in Figure 1) into a single unit called 
the Rondo which can be very convenient for some patients 
such as those that wear eyeglasses.  The similarities in 
physical appearance between the three companies’ cochlear 
implants masks underlying technical approaches.  There are 
major differences in the way that sound is encoded, the 
compression of the sound for transmitting across the 
magnetic coupling, and the way that the electrodes are fired.  
A detailed comparison of these technical differences requires 
extensive fluency in digital signal processing, psycho 
acoustics, and audiology. It is therefore beyond the skills of 
most patients making device selection decisions. The 
interested reader may review appropriate technical journals.  
The patient profile for cochlear implantees varies widely 
in terms of age range and decision making capability. Some 
cochlear implants are implanted in elderly patients whose 
hearing has deteriorated to the point that hearing aids are no 
longer sufficient. Many future recipients are infants or 
toddlers that were born deaf and whose normal hearing 
parents may be unable to bring firsthand knowledge of what 
it is like to live with deafness. Confounding a difficult 
decision with the added parental stress of the situation makes 
rational decision making particularly difficult.  Lastly, some 
recipients are adults that have experienced progressive or 
sudden hearing loss in one or both ears. Common causes are 
tumors (acoustic neuromas) and viral infections but often the 
cause is unknown.  The patient (author) of this paper falls in 
this latter category of a healthy adult with no known cause for 
the hearing loss.   
 
IV. PILOT APPLICATION OF DECISION MAKING FOR 
COCHLEAR IMPLANT SELECTION 
 
A. Challenges of Cochlear Implant Selection 
An author of this paper was recently diagnosed with 
profound hearing loss in one ear resulting in a specialist 
(neurotologist) recommendation for a cochlear implant which 
prompted this study.  The specialist said all three 
manufacturers are able to accommodate the patient’s 
condition and left the final decision of the device to the 
patient.  The patient was handed a stack of company 
brochures and told to come back the following week to make 
the device selection including manufacturer, model(s), 
color(s), and accessories. The patient made an initial device 
selection but then revisited this decision making analytical 
decision making methods. 
Involving patients in the decision making process is 
important in healthcare for a variety of reasons.  This helps 
the patient be more informed about realistic expectations and 
feel greater ownership of the process but also presents a 
number of special decision making challenges.  Choosing a 
cochlear implant manufacturer is a one-time decision akin to 
choosing Android vs. Apple iOS, vs. Windows Phone but 
where the user has never used a cell phone before and will 
never be able to change platforms despite occasional 
upgrades. Some additional factors that complicate the 
decision making include the following. 
1. By its very nature, it is almost always the first time 
someone has made a decision regarding a cochlear 
implant so there is an unfamiliarity with the relevant 
decision criteria.  Furthermore, for many patients, they 
may not even have had a hearing aid.  Also, the 
technology is impossible to fully replicate or simulate and 
trying one out is impossible.  This is similar to buying a 
car without ever having driven a car.   
2. The external processor is very visible and easy to relate to 
compared to the characteristics of the internal device.   
This may result in over emphasizing matters of 
appearance.   Again, relating it to car buying, if one does 
not appreciate the engineering of the engine or 
transmission, it may be difficult to fully judge a car and 
the car buyer may decide on the number of cup holders or 
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the paint color even when major engine and transmission 
differences exist. 
3. The time horizon for different patients (decision makers) 
is significantly different.  It may be a decade for elderly 
patients but 75 years for an infant. This then affects the 
priority on future technological capabilities and long-term 
availability of external devices and support.  Having an 
unsupported cochlear implant would be the equivalent of 
being stuck with a car that can no longer be refueled.   
 
While decision making for hearing aids is known to be 
very difficult as shown by both the joint report of the 
National Academies [2]and at end-user perspective by 
Consumer Reports [18]. The challenge and impact of 
cochlear implant decision making is magnified because 
unlike hearing aids, a patient cannot really test, compare, or 
change their decision after first usage.  
 
B. Cochlear Implant Device Decision Making Criteria 
The patient considered a variety of factors.  A detailed 
website, Cochlear Implant Help [19] has compiled a 
comprehensive collection of information on the current 
cochlear implants made by the three currently US FDA 
approved manufacturers.   
 
TABLE 2: CRITERIA USED FOR COMPARING COCHLEAR 
IMPLANTS 
High level 
Categories 
Criteria 
Performance  Current Implant Technology-How good is the 
implant's current capability utilized 
 Main External Unit – Performance of the system 
with the current most popular BTE (external) 
device 
 Main External Unit’s Waterproof – 
Waterproofness and dustproofness rating of the 
external unit 
Accessories  Secondary External Unit – How appealing is the 
alternative to the standard BTE unit 
 Connection Options – Appeal connectivity 
options such as Bluetooth 
 Bonuses – Bonus programs from the 
manufacturer such as a free upgrade to a next 
generation BTE unit 
Future Issues  Future Implant Technology – How much 
untapped capability is likely to be available in 
the internal (implanted) unit? 
 Warranty & Reliability - Warranty and 
brand reliability 
 
The characteristics considered by the patient are divided 
into three categories: Performance, Accessories, and Future 
Issues.  
 
1) Performance Characteristics 
Performance into three important capabilities.  First is the 
current performance of the implant.  Since this is the unit that 
the patient must live with permanently, the internal unit is 
critical.  It is a function of many design elements such as the 
maximum stimulation rate (pulses per second), number of 
channels, and the maximum number of electrodes that can be 
simultaneously fired.   
The performance of the main external unit can be 
expected to be upgraded over time but is a function of many 
design decisions including the number and placement of 
microphones, power consumption, and sound encoding 
algorithms. 
The external unit is expected to last many years before 
being replaced but experience with cell phones indicates that 
water, sweat, dust, and other contaminants are likely to be a 
problem.  While cochlear implants are improving 
significantly in this area, there is still a long way to go.  
Fortunately, this is one area where there is a well-defined 
industry standard, the International Protection Marking or IP 
Code.  The best IP rated cochlear implant is the Naida from 
Advanced Bionics with an IP57.  The first digit indicates 
solid particle or dust protection and has values ranging from 
zero to six.  The second digit reflects the liquid or more 
specifically water protection and ranges from zero to nine.  
The Naida’s IP57 then means that it is “dust resistant” and 
can be immersed to a depth of one meter for up to 30 
minutes.  
 
2) Accessory Characteristics 
The secondary external unit reflects the fact that two of 
the three manufacturers make an alternate unit to the common 
BTE unit and many clinics have an agreement for patients to 
get a second external processor.  These alternate units provide 
different features that can be quite helpful beyond simply 
having a backup in case the primary one breaks.  Specifically, 
Advanced Bionics’ Neptune has an IP68 rating making it an 
excellent option for swimmers.  Med-El’s Rondo unit 
integrates the magnetic disc and the BTE piece into a single 
unit so there is nothing sitting upon the ear.  While the Rondo 
may not provide ideal placement for microphones, it can be 
very convenient for eyeglass wearers. 
Connectivity options vary across manufacturers. This 
includes accessories for making a Bluetooth connection, 
wireless microphones, and telecoil which is commonly 
available in many public spaces such as theatres and 
churches.  While capabilities are improving, the progress is 
slower than might be expected since regulatory approval by 
both the FCC and FDA may slow feature availability. 
The last accessory related criteria is the included bonuses 
offered.  The manufacturers periodically provide promotional 
add-ons that can be important.  For example, in 2015, Med-El 
offered patients a free Rondo unit.  In a “two-processor” 
clinic, patients could then receive three external processors.  
Since an external processor may cost approximately $6000, 
this can be very beneficial.  Another common promotion 
might be an additional wireless accessory or a free upgrade 
offer to trade in the current processor for a new processor 
when it is approved and available. 
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3) Future Issue Characteristics 
As mentioned earlier, a cochlear implantation is a long-
term decision so it is important to consider what the future 
may hold.  The first issue is Future Implant Technology 
which relates to how much future capability the implant may 
be able provide to upgraded external units over the years.  
While there are many detailed engineering elements that go 
into this, the maximum data rate for transmitting information 
from the processor to the implant is a very important 
performance limiter.  Advanced Bionics supports 1Mb/sec., 
while Med-El is at 0.5 Mb/sec., and Cochlear is at 0.5 
Mb/sec.  For comparison, Audio Compact Discs (CD-DA) 
typically have a bit rate of 1.411 Mb/second and many MP3s 
are encoded at 0.128 Mb/second.  Having said that, real-time 
encoding is complicated and the electrodes also create 
limitations that are likely to always be far from ideal.  While 
cochlear implant recipients may enjoy music, technical 
limitations will prevent them from matching the richness of 
music from a CD or even a heavily compressed MP3.  
Another characteristic of future performance is the maximum 
input dynamic range which is 80dB, 75dB, and 45dB for 
Advanced Bionics, Med-El, and Cochlear respectively.  
The Warranty and Reliability criteria is meant to reflect 
long term reliability and support from the company.  
Currently, it appears that each of the companies offer a ten 
year warranty, therefore, warranty won’t be a differentiator 
among the three alternatives.  A listing from Cochlear 
Implant Help shows the number of reported problems to the 
FDA over time but since this is a count rather than rate, it is 
affected by sales volume and difficult to interpret.  While 
manufacturers have had past problems, it is hard to interpret 
this past data to future reliability since the manufacturers 
have apparently addressed the problems.  A third element of 
this characteristic would be long-term prospects for the 
company.  Current market share or market capitalization for 
the company or parent company could be used as a proxy to 
try to predict long-term likelihood of support but these are 
likely to be poor predictors whether the product will be 
supported in thirty or forty years. 
4) Characteristics Not Included in the Current Model 
Just as in the classic example of a car there are many other 
differences among products that may not be reflected by the 
criteria of the analysis.  Similarly, the cochlear implants vary 
in many other ways beyond those listed which are not 
included in the current model. The patient (author) deemed 
these to be difficult to assess and of lesser importance in his 
usage case.  These could be important for other patients and 
could be added in a future model.  Examples of these other 
factors may include implant size, compatibility with magnetic 
resonance imaging (MRI) machines, implant’s impact 
resistance, battery usage or energy efficiency, and ease of 
use.  Notably absent is cost but it appears that each of the 
three products have similar costs.  Given the current structure 
of the US healthcare system, it is hard to get costs of the 
products, particularly for out of pocket costs, and the patient 
is not asked to factor that into the decision.  If the decision 
was at the level of the insurance or health care provider, cost 
would be important. 
 
C. Patient Input 
The patient did a basic pair-wise comparison of the eight 
criteria using the HDM Software, 2.0 beta, 
http://research1.etm.pdx.edu/hdm2/. The decision hierarchy 
summarized in Table 3.   
Table 3 provides the specific pairwise comparison weights 
for the eight criteria indicating the weight of the criteria listed 
in the row compared against the criteria in the column on a 
100 point scale with 50 being indifferent between the two 
criteria. Only the upper triangular portion of the matrix is 
shown.  The lower triangular values are simply 100 minus the 
upper triangular value. For example, Secondary Exit Unit is 
given 40 compared to the Current Implant Tech. The lower 
triangular value would then be 60.  This indicates that that the 
criteria for Current Implant Tech is 50% (60/40=1.5) more 
important than the Secondary Ext Unit. 
The values in Table 4 describe how the patient perceives 
each of the three alternatives perform on the eight criteria 
relative to the others.  These values are similar to the weights 
from Table 3 but now each row corresponds to a small
 
 
 
Figure 2: Decision hierarchy used for evaluating cochlear implants. 
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TABLE 3: HDM WEIGHTS ASSIGNED FOR THE CRITERIA IN THE ROW VS. THE COLUMN. 
Main%
Ext%
Unit
Main%Ext%
Unit*
Waterproof
Secondary%
Ext%Unit
Connection%
Options Bonuses
Future%
Implant%
Tech
Warranty%
and%
Reliability
Current%Implant%Tech 35 40 40 35 35 60 65
Main%Ext%Unit 40 25 30 40 48 60
Main%Ext%Unit*Waterproof 40 65 50 50 70
Secondary%Ext%Unit 40 35 65 75
Connection%Options 50 60 70
Bonuses 60 70
Future%Implant%Tech 60
Warranty%and%Reliability  
 
TABLE 4: PATIENT’S PERCEIVED RELATIVE STRENGTH FOR EACH ALTERNATIVE ON THE EIGHT CRITERIA. 
Advanced(Bionics
vs.
Med/El
Advanced(Bionics
vs.
Cochlear
Cochlear
vs.
Med/El
A Current(Implant(Tech 60:40 70:30 60:40
B Main(Ext(Unit 55:45 50:50 55:45
C Main(Ext(Unit/Waterproof 65:35 55:45 45:55
D Secondary(Ext(Unit 25:75 55:45 76:24
E Connection(Options 55:45 55:45 50:50
F Bonuses 30:70 50:50 70:30
G Future(Implant(Tech 75:25 82:18 40:60
H Warranty(and(Reliability 50:50 50:50 50:50  
 
triangular matrix comparing the three alternatives.  These 
values are subjective based on significant reading and 
repeated physical examinations of the products but industry 
experts, other patients, and the company’s own personnel are 
likely to have different perspectives.  Some of these may 
change over time as new accessories are introduced, features 
are enabled, and other developments.  In particular, Bonuses 
may be affected by the service provider’s agreements with 
the manufacturer and sales promotions.  At the time of this 
elicitation, Med-El was offering a free Rondo unit (external 
processor) to every new implantee.  Given that a decision 
must be made and the lack of access to independent experts, 
the values given are a best estimate.    
 
D. Pairwise Comparison Results 
HDM’s results in Table 5 indicate that the most important 
characteristic is warranty & reliability or long-term support.  
This is not at all surprising given that the device is intended 
to be permanently implanted.  While the three current 
companies in the US are hard to differentiate on this basis, 
the next two characteristics have a higher differentiation. The 
performance of the main external unit and the level of the 
current implant’s technology are tied for being the next most 
important criteria.  The implant’s technology potential for 
future improvement is the fourth most important criteria.   
The inconsistency score of 0.02 indicates that the patient’s 
elicited values in Table 3 were highly consistent. 
 
TABLE 5: HDM RESULTS DESCRIBING THE RELATIVE 
IMPORTANCE OF EACH CRITERIA. 
Level%1
Preferred+
Device Rank
Current'Implant'Tech 0.15 2
Main'Ext'Unit 0.15 2
Main'Ext'Unit:Waterproof 0.10 6
Secondary'Ext'Unit 0.08 8
Connection'Options 0.11 5
Bonuses 0.09 7
Future'Implant'Tech 0.13 4
Warranty'and'Reliability 0.19 1
Inconsistency 0.02  
Note that results are given to two decimal places to be consistent with the 
number of significant digits in the elicited data of tables 3 and 4. 
 
Next we examine how each of the three products perform 
relative to these eight criteria by synthesizing the values from 
Table 4 into a relative performance in Table 6.  Advanced 
Bionics’ offering is ranked the highest on five criteria, Med-
El is highest on two criteria, and all three are tied on the 
criteria of Warranty and Reliability.  The latter is not 
surprising given the difficulty of distinguishing among the 
performance of the companies on the Warranty and 
Reliability has been discussed earlier.   
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TABLE 6: HDM RESULTS DESCRIBING THE RELATIVE IMPORTANCE OF EACH CRITERION. 
 
 
These results are then collected together to form an 
overall ranking given in Table 7.  The top scoring product is 
that of Advanced Bionics.  
 
TABLE 7: HDM RESULTS DESCRIBING THE RELATIVE 
IMPORTANCE OF EACH CRITERIA. 
Level‐1
Preferred 
Device Rank
Advanced Bionics 0.42 1
Med‐El 0.31 2
Cochlear 0.27 3  
 
Given that the patient is an engineer, this would be a 
reasonable result.  Placing a significantly higher importance 
on the Secondary External Unit and/or Bonuses would be 
required for Med-El to be the preferred alternative holding 
everything else constant in this decision model.  
The patient’s original selection before doing detailed 
research and HDM had been the Med-El system.  Upon 
reflection, this was due to an under appreciation for the 
technical characteristics and over valuing the benefits of the 
Rondo system.  After looking all of this information over, the 
patient contacted the clinic before surgery to change the 
device and company to Advanced Bionics. 
 
V. DISCUSSION 
 
A. Limitations 
The problem of cochlear implant decision making can be 
considered as just one option among a range of other 
treatment alternatives.  Potential alternatives to a cochlear 
implant include traditional hearing aids, bone conduction, 
biotech treatments to “revive” the hair cells in the cochlea.  
While the author carefully considered each of these options, 
detailing that decision making process is beyond the scope of 
this current paper but could be investigated in future work. 
Since one of the paper’s authors needed to make a 
cochlear implant device selection, this provided an 
opportunity to try to frame this decision using tools 
commonly employed in engineering and technology 
management.  It should be recognized that this is only one 
person’s perspective based on available information.  This 
person is by definition – a non-expert in that he has never 
used a cochlear implant at the time of making the decision, is 
not an audiologist, or a doctor specializing in these areas 
(neurotologist).  The criteria selected by the author would 
likely be modified in the future as the patient’s circumstances 
change and as the technology improves.  Perhaps an even 
greater change would occur based on being more fluent in the 
underlying technology. 
 
B. Future Work 
This study was an exploratory study to frame this complex 
decision but future work could follow multiple directions. 
1. The characteristics could be refined to improve their 
definitions and usage as well as possibly adding criteria 
currently excluded as described in section 0.  This might 
be done using fuzzy cognitive maps. 
2. The assessment of the level of performance of cochlear 
implant on each characteristic is based on one patient’s 
perspective.  The patient has no financial interest or other 
association with any of the three vendors and has not yet 
received an implant.  Therefore, while this represents an 
honest and impartial appraisal within the limited time of 
the decision making process, it could be improved by 
further consulting with industry experts.  This could take 
the form of a second expert panel consisting of surgical 
experts, audiologists, and well-informed implanted 
patients which could then assess the performance of the 
cochlear implants.  
3. Testing a more robust decision making model with a 
variety of patients/decision makers to ensure that the 
characteristics reflect the range of concerns and priorities. 
For example, the model was built by a middle-aged 
professional with single-sided deafness.  Certainly the 
priorities will vary for a patient of a toddler or an elderly 
user but there are likely additional concerns the current 
decision maker did not recognize.  
4. Evaluating the benefits of the decision making process on 
decision satisfaction in line with standards in the medical 
decision making field.   
5. This model presumes that a decision for a cochlear 
implant has already been made and the issue is now 
selection of a particular device.  An earlier stage decision 
of whether to get a cochlear implant, an alternate or 
treatment such as bone conduction or potential future 
biotech treatments, or even deferring over time to allow 
technology to progress would be useful for many patients.  
This would require modeling uncertainty regarding future 
technology development, time value of benefits received, 
and the opportunity cost of foregoing options.   
6. Apply Abbas’ robust consistency analysis for the decision 
maker [20]. 
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7. Categorize the criteria so that experts can weigh in on 
technical differences between the cochlear implant 
products. 
 
VI. CONCLUSION 
 
This research was an exploratory study to examine the 
framing of the decision for a complex medical device.  
Pairwise comparison techniques such as AHP and HDM can 
provide a systematic decision support tool to assist the 
decision maker incorporating a range of disparate criteria.  In 
this case, the process of applying HDM was helpful for 
balancing these criteria and making a selection.  The process 
of systematic decision making and reflection resulted in the 
decision maker (patient) changing the product requested 
before surgery was done.   
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